65 related articles for article (PubMed ID: 4665748)
1. [Teratogenic, mutagenic and oncogenic lesions caused by immunosuppressive agents].
Rapp W
Verh Dtsch Ges Inn Med; 1972; 78():761-4. PubMed ID: 4665748
[No Abstract] [Full Text] [Related]
2. Carcinogenic, mutagenic, teratogenic workshop.
Suit H; Hall E; Frei E
Cancer Clin Trials; 1981; 4 Suppl():37-41. PubMed ID: 7307224
[No Abstract] [Full Text] [Related]
3. [Risks of using cytostatic drugs in veterinary medical practice].
Pellicaan CH; Teske E
Tijdschr Diergeneeskd; 1999 Apr; 124(7):210-5. PubMed ID: 10214684
[TBL] [Abstract][Full Text] [Related]
4. [Letter: Evaluation of the teratogenic and mutagenic effects of contraceptives].
Domány Z; László J
Orv Hetil; 1973 Dec; 114(50):3053. PubMed ID: 4769425
[No Abstract] [Full Text] [Related]
5. Antineoplastic and immunosuppressive drugs. 3. Adverse effects and therapeutic problems.
Cridland MD
Drugs; 1972; 3(5):352-65. PubMed ID: 4569065
[No Abstract] [Full Text] [Related]
6. Unusual toxicities from cancer and immunosuppressive therapy.
Kahn SB
Am Fam Physician; 1975 Feb; 11(2):178-9. PubMed ID: 1124712
[No Abstract] [Full Text] [Related]
7. Mutagenic and teratogenic effects of anti-schistosomal praziquantel.
Ni YC; Shao BR; Zhan CQ; Xu YQ; Ha SH; Jiao PY
Chin Med J (Engl); 1982 Jul; 95(7):494-8. PubMed ID: 6816518
[No Abstract] [Full Text] [Related]
8. Thresholds in toxic, teratogenic, mutagenic, and carcinogenic effects.
Freese E
Environ Health Perspect; 1973 Dec; 6():171-8. PubMed ID: 4780780
[No Abstract] [Full Text] [Related]
9. [Embryotoxic and mutagenic activity of ethanol and acetaldehyde in intra-amniotic exposure].
Bariliak IR; Kozachuk SIu
Tsitol Genet; 1983; 17(5):57-60. PubMed ID: 6649057
[TBL] [Abstract][Full Text] [Related]
10. Human uterus retrieval from a multiorgan donor.
Burnett V; McDonald R
Obstet Gynecol; 2007 Jun; 109(6):1458-9; author reply 1459. PubMed ID: 17540830
[No Abstract] [Full Text] [Related]
11. [Transplacental teratogenic, carcinogenic and mutagenic effect of diethylnitrosamine (DENA) following oral administration in rats].
Sydow G
Arch Geschwulstforsch; 1970; 36(4):331-4. PubMed ID: 5513530
[No Abstract] [Full Text] [Related]
12. [Frequency and sequelae of mutagenic and teratogenic substances].
von Kreybig T
Verh Dtsch Ges Inn Med; 1973; 79():63-9. PubMed ID: 4790319
[No Abstract] [Full Text] [Related]
13. Teratogenesis and immunosuppressive treatment.
Danesi R; Del Tacca M
Transplant Proc; 2004 Apr; 36(3):705-7. PubMed ID: 15110638
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppression and teratology: evolving guidelines.
Armenti VT
J Am Soc Nephrol; 2004 Oct; 15(10):2759-60. PubMed ID: 15466283
[No Abstract] [Full Text] [Related]
15. Toxic effects of therapeutic agents: undesirable, teratogenic, mutagenic and carcinogenic effects.
Dent Ther Newsl; 1984 May; 1(4):15-6. PubMed ID: 6388930
[No Abstract] [Full Text] [Related]
16. The inhalation toxicity of phenylglycidyl ether: reproduction, mutagenic, teratogenic, and cytogenic studies.
Terrill JB; Lee KP; Culik R; Kennedy GL
Toxicol Appl Pharmacol; 1982 Jun; 64(2):204-12. PubMed ID: 7123549
[No Abstract] [Full Text] [Related]
17. Mutagenic effects of aflatoxin.
Legator MS
J Am Vet Med Assoc; 1969 Dec; 155(12):2080-3. PubMed ID: 4904474
[No Abstract] [Full Text] [Related]
18. Pregnancy and inflammatory bowel disease.
Korelitz BI
Compr Ther; 1982 Jun; 8(6):67-70. PubMed ID: 6125298
[No Abstract] [Full Text] [Related]
19. [Systemic lupus erythematosus and pregnancy. Study of 44 patients].
Mathías L; Nobile L; Nestarez JE; Cury M; Salomão AJ; Neme B
Ginecol Obstet Mex; 1984 Aug; 52(328):195-9. PubMed ID: 6500280
[No Abstract] [Full Text] [Related]
20. [Pregnancy and immunosuppressive agents].
von Fischer B; Gigon U; Sidiropoulos D; Montandon A
Gynakol Rundsch; 1981; 21(3):141-58. PubMed ID: 7019014
[No Abstract] [Full Text] [Related]
[Next] [New Search]
